PARTICIPATION OF C-MET IN THE PROGRESSION OF HUMAN GASTRIC CANCERS - ANTI-C-MET OLIGONUCLEOTIDES INHIBIT PROLIFERATION OR INVASIVENESS OF GASTRIC-CANCER CELLS
M. Kaji et al., PARTICIPATION OF C-MET IN THE PROGRESSION OF HUMAN GASTRIC CANCERS - ANTI-C-MET OLIGONUCLEOTIDES INHIBIT PROLIFERATION OR INVASIVENESS OF GASTRIC-CANCER CELLS, Cancer gene therapy, 3(6), 1996, pp. 393-404
The protooncogene c-met encodes the receptor for hepatocyte growth fac
tor (HGF), a potent epithelial cell mitogen with scattering activity.
In this study, we first screened c-met expression in human gastric car
cinomas. Twenty-eight of 154 tumors (18%) were positively stained for
MET proteins. The incidence of c-met expression increased with higher
histopathological stages of the cancer. Second, we examined functional
roles of c mel in cultured gastric carcinoma cells, using an antisens
e strategy. Cell lines used were MKN-45, TMK-1, and MKN-28. Among them
, MKN-45 cells exhibited the highest c-met expression and grew in resp
onse to HGF, whereas TMK-1 cells had an ability to invade in an HGF-de
pendent manner. When antisense oligodeoxyribonucleotides complementary
to c-met messenger RNA (mRNA) were administered to the culture medium
, the content of MET protein was selectively decreased in either MKN-4
5 or TMK-1 cells, indicating that the antisense molecules did inhibit
the translation of c-met mRNA. The growth of MKN-45 cells was markedly
inhibited by the antisense c-met oligonucleotides in a dose-dependent
manner, but not by sense or scrambled controls. The antisense oligonu
cleotides also effectively inhibited the migration of TMK-1 cells. The
se result indicate that c-met gene products may be causally related to
the proliferation or invasion of gastric cancer cells, and that antis
ense c-met DNA has the potential to help circumvent the progression of
gastric cancers.